This project is funded by the UK National Institute for Health Research to set up a full-fledged Global Health Research Unit (GHRU) through a grant awarded to the cGPS (Centre for Genomic Pathogen Sur
Eravacycline (ERV) has emerged as a therapeutic option for the treatment of carbapenem-resistant pathogens. However, the advent of heteroresistance (HR) to ERV poses a challenge to these therapeutic s
